Authors' Reply to Ulrich: Comment on `Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use Them Safely and Effectively'

被引：0

作者：

Baldwin, David S. ^{[1
]}

Chamberlain, Samuel R. ^{[1
]}

机构：

[1] Univ Southampton, Univ Dept Psychiat Clin & Expt Sci, CNS Psychiat, Fac Med,Coll Keep, 4-12 Terminus Terrace, Southampton SO14 3DT, Hants, England

来源：

CNS DRUGS | 2022年 / 36卷 / 01期

基金：

英国惠康基金;

关键词：

D O I：

10.1007/s40263-021-00882-1

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：103 / 103

页数：1

共 7 条

[1] Authors’ Reply to Ulrich: Comment on ‘Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use Them Safely and Effectively’
David S. Baldwin
Samuel R. Chamberlain
CNS Drugs, 2022, 36 : 103 - 103
[2] Comment on: “Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively”
Sven Ulrich
CNS Drugs, 2022, 36 : 101 - 102
[3] Comment on: "Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively"
Ulrich, Sven
CNS DRUGS, 2022, 36 (01) : 101 - 102
[4] Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively
Samuel R. Chamberlain
David S. Baldwin
CNS Drugs, 2021, 35 : 703 - 716
[5] Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively
Chamberlain, Samuel R.
Baldwin, David S.
CNS DRUGS, 2021, 35 (07) : 703 - 716
[6] Correction to: Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively
Samuel R. Chamberlain
David S. Baldwin
CNS Drugs, 2022, 36 : 97 - 97
[7] Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively (vol 35, pg 703, 2021)
Chamberlain, Samuel R.
Baldwin, David S.
CNS DRUGS, 2022, 36 (01) : 97 - 97

← 1 →